<?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName art560.dtd?>
<?SourceDTD.Version 5.6.0?>
<?ConverterInfo.XSLTName elsevier2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<?origin publisher?>
<?FILEmeta_OCARTO100237 xml ?>
<?FILEmain xml ?>
<?FILEmain pdf ?>
<?FILEgr1 jpg ?>
<?FILEgr2 jpg ?>
<?FILEgr3 jpg ?>
<?FILEgr4 jpg ?>
<?FILEmmc1 pdf ?>
<?FILEmmc2 txt ?>
<?FILEmmc3 txt ?>
<?FILEmmc4 xlsx ?>
<?FILEmmc5 txt ?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Osteoarthr Cartil Open</journal-id>
    <journal-id journal-id-type="iso-abbrev">Osteoarthr Cartil Open</journal-id>
    <journal-title-group>
      <journal-title>Osteoarthritis and Cartilage Open</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2665-9131</issn>
    <publisher>
      <publisher-name>Elsevier</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9718079</article-id>
    <article-id pub-id-type="pii">S2665-9131(22)00005-X</article-id>
    <article-id pub-id-type="doi">10.1016/j.ocarto.2022.100237</article-id>
    <article-id pub-id-type="publisher-id">100237</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Virtual Special Issue on: Omics Phenotyping; Edited by Mohit Kapoor, AliMobasheri, Shabana Amanda Ali and Annemarie Lang</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Osteoarthritis Data Integration Portal (OsteoDIP): A web-based gene and non-coding RNA expression database</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="au1">
        <name>
          <surname>Pastrello</surname>
          <given-names>Chiara</given-names>
        </name>
        <email>chiara.pastre@gmail.com</email>
        <xref rid="aff1" ref-type="aff">a</xref>
        <xref rid="aff2" ref-type="aff">b</xref>
      </contrib>
      <contrib contrib-type="author" id="au2">
        <name>
          <surname>Abovsky</surname>
          <given-names>Mark</given-names>
        </name>
        <email>mabovsky@yahoo.com</email>
        <xref rid="aff1" ref-type="aff">a</xref>
        <xref rid="aff2" ref-type="aff">b</xref>
      </contrib>
      <contrib contrib-type="author" id="au3">
        <name>
          <surname>Lu</surname>
          <given-names>Richard</given-names>
        </name>
        <email>richard.lu@uhnresearch.ca</email>
        <xref rid="aff1" ref-type="aff">a</xref>
        <xref rid="aff2" ref-type="aff">b</xref>
      </contrib>
      <contrib contrib-type="author" id="au4">
        <name>
          <surname>Ahmed</surname>
          <given-names>Zuhaib</given-names>
        </name>
        <email>zuhaibzulfiqarahmed@gmail.com</email>
        <xref rid="aff1" ref-type="aff">a</xref>
        <xref rid="aff2" ref-type="aff">b</xref>
      </contrib>
      <contrib contrib-type="author" id="au5">
        <name>
          <surname>Kotlyar</surname>
          <given-names>Max</given-names>
        </name>
        <email>maxk.email@gmail.com</email>
        <xref rid="aff1" ref-type="aff">a</xref>
        <xref rid="aff2" ref-type="aff">b</xref>
      </contrib>
      <contrib contrib-type="author" id="au6">
        <name>
          <surname>Veillette</surname>
          <given-names>Christian</given-names>
        </name>
        <email>Christian.Veillette@uhn.ca</email>
        <xref rid="aff1" ref-type="aff">a</xref>
      </contrib>
      <contrib contrib-type="author" id="au7">
        <name>
          <surname>Jurisica</surname>
          <given-names>Igor</given-names>
        </name>
        <email>juris@ai.utoronto.ca</email>
        <xref rid="aff1" ref-type="aff">a</xref>
        <xref rid="aff2" ref-type="aff">b</xref>
        <xref rid="aff3" ref-type="aff">c</xref>
        <xref rid="aff4" ref-type="aff">d</xref>
        <xref rid="cor1" ref-type="corresp">∗</xref>
      </contrib>
      <aff id="aff1"><label>a</label>Osteoarthritis Research Program, Division of Orthopedic Surgery, Schroeder Arthritis Institute, University Health Network, Toronto, Canada</aff>
      <aff id="aff2"><label>b</label>Data Science Discovery Centre for Chronic Diseases, Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, Canada</aff>
      <aff id="aff3"><label>c</label>Departments of Medical Biophysics and Computer Science, University of Toronto, Toronto, ON, Canada</aff>
      <aff id="aff4"><label>d</label>Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovakia</aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>∗</label>Corresponding author. Krembil Discovery Tower, 5KD-407 60 Leonard Avenue, Toronto, ON, M5T 0S8, Canada. <email>juris@ai.utoronto.ca</email></corresp>
    </author-notes>
    <pub-date pub-type="pmc-release">
      <day>27</day>
      <month>1</month>
      <year>2022</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
    <pub-date pub-type="collection">
      <month>3</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>27</day>
      <month>1</month>
      <year>2022</year>
    </pub-date>
    <volume>4</volume>
    <issue>1</issue>
    <elocation-id>100237</elocation-id>
    <history>
      <date date-type="received">
        <day>1</day>
        <month>3</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>19</day>
        <month>1</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2022 The Authors</copyright-statement>
      <copyright-year>2022</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
        <license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
      </license>
    </permissions>
    <abstract id="abs0010">
      <sec>
        <title>Objective</title>
        <p>OsteoDIP aims to collect and provide, in a simple searchable format, curated high throughput RNA expression data related to osteoarthritis.</p>
      </sec>
      <sec>
        <title>Design</title>
        <p>Datasets are collected annually by searching “osteoarthritis gene expression profile” in PubMed. Only publications containing patient data and a list of differentially expressed genes are considered. From 2020, the search has expanded to include non-coding RNAs. Moreover, a search in GEO for “osteoarthritis” datasets has been performed using ‘<italic>Homo sapiens</italic>' and ‘Expression profiling by array’ filters. Annotations for genes linked to osteoarthritis have been downloaded from external databases.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p>Out of 1204 curated papers, 63 have been included in OsteoDIP, while GEO curation led to the collection of 28 datasets. Literature data provides a snapshot of osteoarthritis research derived from 1924 human samples, while GEO datasets provide expression for additional 1012 patients. Similar to osteoarthritis literature, OsteoDIP data has been created mostly from studies focused on knee, and the tissue most frequently investigated is cartilage. GEO data sets were fully integrated with associated clinical data. We showcase examples and use cases applicable for translational research in osteoarthritis.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p>OsteoDIP is publicly available at <ext-link ext-link-type="uri" xlink:href="http://ophid.utoronto.ca/OsteoDIP" id="intref0010">http://ophid.utoronto.ca/OsteoDIP</ext-link>. The website is easy to navigate and all the data is available for download. Data consolidation allows researchers to perform comparisons across studies and to combine data from different datasets. Our examples show how OsteoDIP can integrate with and improve osteoarthritis researchers’ pipelines.</p>
      </sec>
    </abstract>
    <kwd-group id="kwrds0010">
      <title>Keywords</title>
      <kwd>Data integration</kwd>
      <kwd>Gene expression</kwd>
      <kwd>Long non-coding RNA</kwd>
      <kwd>microRNA</kwd>
      <kwd>integrative computational biology</kwd>
    </kwd-group>
    <kwd-group id="kwrds0010a">
      <title>Abbreviations</title>
      <kwd>OA, osteoarthritis</kwd>
      <kwd>OsteoDIP, Osteoarthritis Data Integration Portal</kwd>
      <kwd>TCGA, The Cancer Genome Atlas</kwd>
      <kwd>GWAS, Genome Wide Assocaition Studies</kwd>
      <kwd>IID, Integrated Interactions Database</kwd>
      <kwd>pathDIP, Pathway Data Integration Portal</kwd>
      <kwd>mirDIP, MicroRNA Data Integration Portal</kwd>
      <kwd>GEO, Gene Expression Omnibus</kwd>
      <kwd>HGNC, HUGO Gene Nomenclature Committee</kwd>
      <kwd>NAViGaTOR, NetworkAnalysis, Visualization, &amp; Graphing TORonto</kwd>
    </kwd-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <label>1</label>
    <title>Introduction</title>
    <p id="p0010">High throughput data have become essential for unbiased investigations of important biomedical research questions in the last two decades. The type, amount and quality of data analyzed has progressively increased, providing biomedical researchers with the resources needed to create a molecular view of the system being studied gradually closer to a “whole picture”. Every set of data collected contributes to advance our understanding of complex diseases, including osteoarthritis (OA). Nonetheless, it is only one stroke in a much bigger painting, mostly because OA is not homogeneous but rather represents a spectrum of diseases: patients with the same disease may respond differently to the same treatment and the disease may progress differently due to patient heterogeneity. Individual biological assays can detect a high number of molecules (for example proteins, microRNAs, metabolites, gene expression quantification) or their status (for example mutation, methylation or post-transcriptional modification), but in a cell all these molecules act in concert, and individual patients are characterized by a combination of these perturbations. To fathom how they influence health and disease state, we need to combine them using corresponding networks – microRNA:gene, protein:protein, pathways, etc. Furthermore, even considering only one type of data, different datasets can include patients with the same disease, but might be trying to answer different questions, or include patients with different clinicopathological features. However, even when the clinical question and the clinicopathological features are the same, technical and biological heterogeneity can lead to different results – most of which are still valuable, but represent small (and sometimes redundant) pieces of the disease's molecular puzzle [<xref rid="bib1" ref-type="bibr">1</xref>].</p>
    <p id="p0015">Intuitively, data integration across datasets and molecules is key to gather more information and depict a more complete picture. Many disease-specific databases already harness this potential, especially for cancer (the most well-known being cBioPortal, that includes, among others, the huge collection of data from TCGA [<xref rid="bib2" ref-type="bibr">2</xref>]).</p>
    <p id="p0020">In OA, many proteomics, gene and non-coding RNA expression, methylation, metabolomics and genome-wide association studies (GWAS) have been performed (reviewed in Ref. [<xref rid="bib3" ref-type="bibr">3</xref>]). Resources collecting and annotating omics data in OA, though, are limited. SkeletalVis collects and re-analyzes transcriptomics datasets linked to skeletal diseases, including, but not focusing on, OA [<xref rid="bib4" ref-type="bibr">4</xref>]. A researcher can use the database to calculate fold change and related enrichment analyses in one dataset at a time, or compare different datasets one gene or one signature at a time. OATargets collects data on model organisms and the effect of gene manipulation on their OA phenotypes [<xref rid="bib5" ref-type="bibr">5</xref>]. In this paper we present OsteoDIP, a database collecting and annotating OA-specific omics data from human studies.</p>
  </sec>
  <sec id="sec2">
    <label>2</label>
    <title>Method</title>
    <sec id="sec2.1">
      <label>2.1</label>
      <title>Data collection</title>
      <p id="p0025">OsteoDIP primarily focuses on genes found to be linked to OA using high-throughput techniques (for example microarray or RNAseq). To collect such data, we performed this exact search in PubMed: “osteoarthritis gene expression profile”. Only papers that included patient diagnosis annotation for at least 4 patients and that provided the list of differential genes were collected. The search was first performed in October 2016, with annual updates. At each update cycle, we verify whether any paper has been retracted and, in such case, remove it from the database. In 2020, the search was extended to include also non-coding RNA molecules, using the same collection of articles as the ones used in the recent review [<xref rid="bib6" ref-type="bibr">6</xref>]. Gene symbols are updated every release to the latest HGNC version [<xref rid="bib7" ref-type="bibr">7</xref>], microRNAs to the latest miRBase [<xref rid="bib8" ref-type="bibr">8</xref>] and long non-coding RNAs to the latest LNCipedia version [<xref rid="bib9" ref-type="bibr">9</xref>].</p>
      <p id="p0030">With OsteoDIP, we provide a platform and initial curation with the aim to make available high-quality data for translational research in osteoarthritis. To ensure both high data quality and coverage, we opened the platform for contributed curation. For example, OsteoDIP includes 18 low-throughput protein expression and SNP data sets and radiographic biomarkers data from 5 studies curated and provided by Dr. Stuart Faulkner, Center for the Advancement of Sustainable Medical Innovation, Oxford University.</p>
    </sec>
    <sec id="sec2.2">
      <label>2.2</label>
      <title>GEO data collection and normalization</title>
      <p id="p0035">Datasets were curated from GEO [<xref rid="bib10" ref-type="bibr">10</xref>] using 'osteoarthritis' as a search term and ‘<italic>Homo sapiens</italic>' and ‘Expression profiling by array’ as filters. For curation, the same criteria used for data collection were applied. Moreover, we checked that no overlap among samples (based on GSM identifier) was present. Series matrix files were then downloaded for the datasets of interest, and expression and clinical data were separated. For each expression table, if probeset to gene symbol mapping was not provided, it was created using the annotations present in GEO platform pages. For each clinical table, data was consolidated to be searchable in the database (for example, sex was transformed to F and M for all datasets, replacing “Female”, “female”, “Male” or “male”).</p>
      <p id="p0040">If raw data was available, normalization was performed using R 4.0.3 [<xref rid="bib11" ref-type="bibr">11</xref>] with packages limma 3.46.0 [<xref rid="bib12" ref-type="bibr">12</xref>], affy 1.68.0 [<xref rid="bib13" ref-type="bibr">13</xref>] or oligo 1.54.1 [<xref rid="bib14" ref-type="bibr">14</xref>]. Most of the datasets were RMA-normalized, but the full list of datasets and their normalization methods is available in <xref rid="appsec1" ref-type="sec">Supplementary Table 1</xref>.</p>
    </sec>
    <sec id="sec2.3">
      <label>2.3</label>
      <title>Annotation</title>
      <p id="p0045">OsteoDIP provides, for each gene of interest present in at least one of the curated papers, a set of annotation data from external databases. Disease annotation is collected from DisGeNET [<xref rid="bib15" ref-type="bibr">15</xref>], protein secretion data from The Human Protein Atlas [<xref rid="bib16" ref-type="bibr">16</xref>] and MetazSecKB [<xref rid="bib17" ref-type="bibr">17</xref>], SNPs from the GWAS Catalog [<xref rid="bib18" ref-type="bibr">18</xref>], human protein-protein interaction (PPI) data from the Integrated Interactions Database (IID) ver. 2020–11 (with interaction annotations synovial macrophages, chondrocytes, growth plate cartilage, synovial membrane or articular cartilage) [<xref rid="bib19" ref-type="bibr">19</xref>]. We also provide the number of conserved PPIs per species: conserved PPIs are determined by mapping experimentally detected human PPIs to orthologous protein pairs in 17 other species. Mappings are based on 1:1 orthologs from Ensembl [<xref rid="bib20" ref-type="bibr">20</xref>] release 100.</p>
    </sec>
    <sec id="sec2.4">
      <label>2.4</label>
      <title>Database</title>
      <p id="p0050">The web interface to the OsteoDIP database is implemented in the Java Server Faces framework running on IBM WebSphere Application Server (ver. 9.0). The backend storage deployed IBM DB2 database (ver. 11.1) engine. For performance improvement, the WebSphere and DB2 are placed on different virtual instances of IBM P770 and P750, running AIX (ver. 7.2). The OsteoDIP Data Integration Portal (DIP) is freely available at <ext-link ext-link-type="uri" xlink:href="http://ophid.utoronto.ca/OsteoDIP" id="intref0015">http://ophid.utoronto.ca/OsteoDIP</ext-link>, and online documentation provides more details for every page.</p>
    </sec>
    <sec id="sec2.5">
      <label>2.5</label>
      <title>Use cases</title>
      <p id="p0055"><underline>Descriptive analyses</underline>. Descriptive analyses of OsteoDIP have been performed using search results and tables obtained from the website at the “Matrix” page. Top deregulated genes were extracted from the matrix of all deregulated molecules in OsteoDIP, and the microRNAs targeting them were obtained from mirDIP [<xref rid="bib21" ref-type="bibr">21</xref>] (<ext-link ext-link-type="uri" xlink:href="http://ophid.utoronto.ca/mirDIP" id="intref0020">http://ophid.utoronto.ca/mirDIP</ext-link>) using the threshold “very high”. Human PPI data among top deregulated genes were obtained from the Integrated Interactions Database (IID) ver. 2020–11 (<ext-link ext-link-type="uri" xlink:href="http://ophid.utoronto.ca/iid" id="intref0025">http://ophid.utoronto.ca/iid</ext-link>).</p>
      <p id="p0060"><underline>OA signature</underline>. An OA signature was collected from Ref. [<xref rid="bib22" ref-type="bibr">22</xref>]. Gene names were used to query the GEO page in OsteoDIP, and the downloaded sets of tables (clinical, expression and normalized expression data) were used in R 4.0.3 to calculate fold changes and moderated <italic>t</italic>-test p-values using the limma package ver. 3.44.3. Datasets were used if they had patients and healthy controls, at least 3 independent samples per group, and patients were not receiving treatments. Genes that had a significant p-value were plotted using ggplot2 ver. 3.3.3.</p>
      <p id="p0065"><underline>MicroRNA review</underline>. A recent review listed the microRNAs that have a protective or destructive role in OA [<xref rid="bib24" ref-type="bibr">24</xref>]. We collected the microRNAs, converted them to miRbase v.22 IDs using miRBaseConverter 1.12 in R 4.3.0, and searched for them in the microRNA search page of OsteoDIP. Furthermore, we investigated the targets of such microRNAs present in the network depicted in <xref rid="fig2" ref-type="fig">Fig. 2</xref> of the review. All the genes were searched for in OsteoDIP. We next investigated the overlap between the two lists of microRNAs and the microRNAs targeting top deregulated genes from OsteoDIP. Hypergeometric distribution test was performed in R 4.0.3. A network depicting the microRNAs from the two lists targeting OA genes has been built using NAViGaTOR 3.0.14 [<xref rid="bib25" ref-type="bibr">25</xref>]. Conservation of the network's protein:protein interactions in different species was obtained from IID ver. 2020–11.</p>
      <p id="p0070"><underline>Hip and knee cartilage comparison</underline>. To investigate possible differences between hip and knee expression, we analyzed the matrices including all the protein coding genes that were deregulated in cartilage hip OA and the ones deregulated in cartilage knee OA. Overlap and differences between the two sets of genes were calculated in R 4.0.3. Pathway enrichment analysis for each specific set (genes deregulated only in hip or genes deregulated only in knee) was performed in pathDIP 4.1 [<xref rid="bib26" ref-type="bibr">26</xref>] selecting BioCarta, EHMN, HumanCyc, INOH, IPAVS, NetPath, Panter_Pathways, PID, REACTOME, Signalink2.0, SIGNOR 2.0, Spike, STKE, <ext-link ext-link-type="uri" xlink:href="http://systems.biology.org" id="intref0030">systems.biology.org</ext-link>, Uniprot_Pathways and Wikipathways as sources. Enrichment was conducted using the sources separately, and only pathways with adjusted p-value (False Discovery Rate, BH method) ​&lt; ​0.01 were retained.</p>
      <p id="p0075"><underline>MALAT1</underline>. MALAT1 targets were retrieved from LncTarD [<xref rid="bib27" ref-type="bibr">27</xref>]. Of the retrieved targets, microRNAs were then used to query mirDIP (threshold “very high”) to obtain microRNA:gene interactions. Only gene targets of the microRNAs or of MALAT1 that were present in OsteoDIP were retained. A network was created using NAViGaTOR 3.0.14. Pathway enrichment analysis of gene targets was performed in pathDIP 4.1 using the same databases listed above. Enrichment was computed using the combined pathway source databases, and only pathways with adjusted p-value (False Discovery Rate, BH method) ​&lt; ​0.01 were retained. Each gene was then annotated with the pathway from the enriched list with the lowest p-value.</p>
    </sec>
  </sec>
  <sec id="sec3">
    <label>3</label>
    <title>Results</title>
    <sec id="sec3.1">
      <label>3.1</label>
      <title>Data</title>
      <p id="p0080">We have considered 1204 papers as of December 2020 (<xref rid="fig1" ref-type="fig">Fig. 1</xref>A), 63 of which have been collected in OsteoDIP after necessary exclusions. While many papers have been excluded due to our curation choices (for example non-original data, model organism data), it stands out that 135 papers were excluded because the data were not available – highlighting once more how the lack of data sharing affects curation efforts worldwide. As visible in <xref rid="fig1" ref-type="fig">Fig. 1</xref>B, OsteoDIP reflects the literature distribution, with most papers focusing on knee OA, and more frequently on cartilage tissues.<fig id="fig1"><label>Fig. 1</label><caption><p><bold>(A)</bold> shows the curation process, from the starting point of 1204 papers to the final one of 63 collected for OsteoDIP. Numbers show how many studies were excluded and the reason for exclusion. “Non patients” refers to studies where data were not collected from human samples (but rather using, for example, model organisms). “non-HT” refers to non-high-throughput studies (i.e., studies exploring only one or a few genes or proteins). “non-OA” refers to studies not focused on osteoarthritis (for example, studies that mention the disease in the paper but study some other disease). “non available” refers to studies where the data are not available or data/paper are in a language other than English. “non applicable” refers to studies that include too few samples or to papers focused on OA but that do not include signatures (for example reviews). “non original” refers to papers that re-analyze previously published data. <bold>(B)</bold> shows the number of studies and datasets that belonged to each category, and how many contributed each different joint and tissue. N.s. ​= ​not specified.</p></caption><alt-text id="alttext0035">Fig. 1</alt-text><graphic xlink:href="gr1"/></fig><fig id="fig2"><label>Fig. 2</label><caption><p>Network of top deregulated genes and protective/destructive microRNAs. MicroRNA:gene interactions were obtained from mirDIP, PPIs were obtained from IID, and protective/destructive microRNAs are from Endisha et al. Edge thickness is proportional to the number of species where the edge is conserved. Genes are colored according to Gene Ontology Biological Process terms. Node width is proportional to the number of studies where a gene is down-regulated, while the height is proportional to the number of studies where a gene is up-regulated.</p></caption><alt-text id="alttext0040">Fig. 2</alt-text><graphic xlink:href="gr2"/></fig></p>
      <p id="p0085">GEO curation led to the collection of 28 datasets. Consolidated clinical data from such datasets is available at the OsteoDIP GEO Clinical page, which shows that the datasets provide expression data for 1012 patients with heterogeneous types of data. Curation revealed that less than half of the datasets (13/28) include age annotation for the samples and only one (GSE15227) includes grade. The collection of papers, on the other hand, provides a view of OA obtained from 1924 samples (from different comparisons, but most frequently – in 39 papers – OA samples are compared to healthy controls). Four studies are present both in the curated and in the GEO dataset pages (PMID: 16508983, 24229462, 29258882, 29973527).</p>
      <p id="p0090">Molecules deregulated in at least one study include 8905 genes, 402 lncRNAs, 56 microRNAs and 58 circRNAs. The distribution of gene deregulation and its direction is shown in <xref rid="appsec1" ref-type="sec">Supplementary Fig. 1</xref>.</p>
    </sec>
    <sec id="sec3.2">
      <label>3.2</label>
      <title>Use cases</title>
      <p id="p0095">OsteoDIP can be used for different types of studies, for example:<list list-type="simple" id="ulist0010"><list-item id="u0010"><label>•</label><p id="p0100">Study specific genes of interest, where they have been published, to which conditions they have been linked, and which of their interactions are conserved across species.</p></list-item><list-item id="u0015"><label>•</label><p id="p0105">Study genes linked to specific tissues and/or joints and/or comparisons. We show this in: “Hip and knee cartilage comparison” case.</p></list-item><list-item id="u0020"><label>•</label><p id="p0110">Study specific noncoding RNAs of interest, where they have been published, to which conditions they have been linked and, in the case of microRNAs, which genes they target. Two cases are shown: “MALAT1″ and “microRNA review".</p></list-item><list-item id="u0025"><label>•</label><p id="p0115">Perform analyses on OA related datasets, using consolidated annotation data that facilitates comparisons across datasets. We provide an example in “OA signature"</p></list-item></list></p>
      <p id="p0120"><underline>Descriptive analyses</underline>. The most frequently dowregulated molecule is the gene APOD (9 studies), while the most frequently upregulated is the gene COL5A1 (14 studies). Searching for APOD in OsteoDIP, we can see that it is secreted, and that it interacts with 108 other proteins. Of these interactions, 84 are conserved in mouse, 83 in cat and guinea pig, and 82 in cow and rat, suggesting they would be the best animal models to study APOD's effect on OA. Of the 108 interactors, 52 are listed as deregulated in at least one study in OsteoDIP. Similarly, searching for COL5A1, we can see that it is secreted as well, and that it is annotated with a score of 0.73 with the disease Ehlers-Danlos syndrome type 1. There are 317 COL5A1 protein interactions reported in IID. Of the 317 interactors, 256 are annotated with at least one study where they are deregulated, but the highest number of conserved interactions is only 43, in mouse and pig.</p>
      <p id="p0125">We then explored top deregulated molecules. Focusing on those deregulated in at least 8 studies, we identified 138 genes that are connected by 624 PPIs, 607 of which are annotated with synovial or cartilage specific tissues. <xref rid="tbl1" ref-type="table">Table 1</xref> shows that most PPIs are conserved across mammals, with cat being the species with the highest number of conserved PPIs.<table-wrap position="float" id="tbl1"><label>Table 1</label><caption><p>Species and number of PPIs conserved in that species.</p></caption><alt-text id="alttext0055">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th>2. Species</th><th># PPIs</th></tr></thead><tbody><tr><td>3. Cat</td><td>599</td></tr><tr><td>4. Horse</td><td>574</td></tr><tr><td>5. Sheep</td><td>573</td></tr><tr><td>6. Cow</td><td>571</td></tr><tr><td>7. Pig</td><td>555</td></tr><tr><td>8. Mouse</td><td>549</td></tr><tr><td>9. Dog</td><td>544</td></tr><tr><td>10. Guinea pig</td><td>521</td></tr><tr><td>11. Rabbit</td><td>472</td></tr><tr><td>12. Rat</td><td>464</td></tr><tr><td>13. Chicken</td><td>404</td></tr><tr><td>14. Turkey</td><td>357</td></tr><tr><td>15. Duck</td><td>309</td></tr><tr><td>16. Worm</td><td>7</td></tr><tr><td>17. Fly</td><td>3</td></tr><tr><td>18. Yeast</td><td>1</td></tr><tr><td>19. Alpaca</td><td>0</td></tr></tbody></table></table-wrap></p>
      <p id="p0130"><underline>MicroRNA review</underline>. Using mirDIP, we identified 701 microRNAs that target the top genes described above. OsteoDIP includes 41 of these microRNAs, providing further evidence of their importance to OA. To further annotate the microRNAs, we looked at the overlap between them and the protective and destructive microRNAs [<xref rid="bib24" ref-type="bibr">24</xref>]. Hypergeometric test provides evidence that the top genes are significantly targeted by the reviewed microRNAs (p-value 5.485815e-08 for destructive microRNAs and 3.682239e-10 for protective ones). A network built using such overlapping microRNAs and their gene targets present in OsteoDIP shows 18 genes targeted only by protective microRNAs, among which the most downregulated gene is CHI3L1, a gene that supports OA progression facilitating ECM degradation through MMP9 and that degrades key proteins such as proteoglycan, collagen and osteonectin [<xref rid="bib28" ref-type="bibr">28</xref>]. Furthermore, 10 genes are targeted only by destructive microRNAs, among which the most downregulated gene is NQO1, an antioxidant enzyme regulated by Nrf2 and involved in preventing cartilage degradation [<xref rid="bib29" ref-type="bibr">29</xref>] (<xref rid="fig2" ref-type="fig">Fig. 2</xref>).</p>
      <p id="p0135">We then looked for the microRNAs present in the review: 6 cartilage protective (hsa-miR-24–3p, hsa-miR-27a-3p, hsa-miR-27b-3p, hsa-miR-193b-3p, hsa-miR-210–3p and hsa-miR-30a-5p) and 10 cartilage destructive (hsa-miR-139–5p, hsa-miR-181a-5p, hsa-miR-23a-3p, hsa-miR-34a-5p, hsa-miR-4454, hsa-miR-203a-3p, hsa-miR-223–3p, hsa-miR-302b-3p, hsa-miR-381–3p and hsa-miR-483–5p) are found in OsteoDIP, all being annotated as deregulated in only one paper each. Among the 997 genes identified in the review targeted only by cartilage-destructive microRNAs, 390 were found to be deregulated in one or more studies. Interestingly, RNF34, highlighted in the text for its cartilage-destructive link, has been shown to be downregulated in two studies comparing OA knee cartilages to healthy controls. 833 of 1854 genes targeted only by cartilage-protective microRNAs were also found to be deregulated in at least one study. HAS3 has been highlighted for its link to protective microRNAs and it was found downregulated in one study where normal knee synovial tissue was compared to inflamed areas of OA knee. Almost 47% of all the targets of the reviewed microRNAs are described as deregulated in at least one OA study, suggesting a strong connection between the microRNAs, the genes and OA.</p>
      <p id="p0140"><underline>OA signature</underline>. A recent blood diagnostic signature has been shown to separate OA from healthy samples [<xref rid="bib22" ref-type="bibr">22</xref>]. A researcher might be interested to know wether the identified genes have a role in OA pathogenesis; thus, we tested in which datasets such genes were differentially expressed in OA compared to healthy individuals. Using the 4 listed genes, we collected from OsteoDIP their expression from 28 GEO datasets. All 4 genes were present, and 6 datasets passed our filtering criteria. <xref rid="tbl2" ref-type="table">Table 2</xref> shows the number of samples and distribution of expression in healthy and OA samples in each dataset. As expected, there was variability across the datasets, and IL18 and SRSF2 were the only genes with significant differential expression (<xref rid="fig3" ref-type="fig">Fig. 3</xref>). SRSF2 was differential in a dataset that studied meniscal tissue (GSE98918) and IL18 in a dataset that examined synovial tissues (GSE82107). Interestingly, the two datasets with the strongest differential expression for the genes of interest, GSE82107 and GSE143514, were both derived from synovial tissues, while the remaining datasets were derived from meniscus, synovial fibroblasts and cartilage tissues. This suggests a possible connection between synovial tissue OA molecular landmark and the OA blood signature genes. This also further highlights the benefit of diverse samples and their rich annotation.<table-wrap position="float" id="tbl2"><label>Table 2</label><caption><p><bold>Features of datasets used in OA signature example</bold>.</p></caption><alt-text id="alttext0060">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Feature</th><th>GSE117999</th><th>GSE143514</th><th>GSE19060</th><th>GSE29746</th><th>GSE82107</th><th>GSE98918</th></tr></thead><tbody><tr><td>OA <bold>samples</bold></td><td>12</td><td>5</td><td>5</td><td>11</td><td>10</td><td>12</td></tr><tr><td>Healthy <bold>samples</bold></td><td>12</td><td>3</td><td>3</td><td>11</td><td>7</td><td>12</td></tr><tr><td><bold>Mean <italic>CCR6</italic></bold> OA</td><td>13.0832</td><td>0.4914</td><td>3.6073</td><td>8.2111</td><td>3.4547</td><td>13.2728</td></tr><tr><td><bold>SD</bold></td><td>1.0046</td><td>0.089</td><td>0.1007</td><td>0.2236</td><td>0.1211</td><td>0.3484</td></tr><tr><td><bold>c.o.v</bold></td><td>0.0768</td><td>0.1811</td><td>0.0279</td><td>0.0272</td><td>0.0351</td><td>0.0262</td></tr><tr><td><bold>mean <italic>CLEC7A</italic></bold> OA</td><td>8.0407</td><td>13.177</td><td>4.0879</td><td>7.9584</td><td>8.3056</td><td>7.9595</td></tr><tr><td><bold>SD</bold></td><td>0.5727</td><td>10.1985</td><td>0.1294</td><td>0.0543</td><td>1.163</td><td>0.2572</td></tr><tr><td><bold>c.o.v</bold></td><td>0.0712</td><td>0.774</td><td>0.0317</td><td>0.0068</td><td>0.14</td><td>0.0323</td></tr><tr><td><bold>mean <italic>IL18</italic></bold> OA</td><td>7.9868</td><td>22.6703</td><td>3.4045</td><td>8.5381</td><td>4.7233</td><td>8.1281</td></tr><tr><td><bold>SD</bold></td><td>0.3115</td><td>3.79</td><td>0.0946</td><td>0.348</td><td>0.4194</td><td>0.2498</td></tr><tr><td><bold>c.o.v</bold></td><td>0.039</td><td>0.1672</td><td>0.0278</td><td>0.0408</td><td>0.0888</td><td>0.0307</td></tr><tr><td><bold>mean <italic>SRSF2</italic></bold> OA</td><td>11.9468</td><td>101.7188</td><td>10.9003</td><td>14.7229</td><td>7.2814</td><td>11.8503</td></tr><tr><td><bold>SD</bold></td><td>0.9364</td><td>10.4052</td><td>0.3949</td><td>0.2297</td><td>0.5771</td><td>0.3822</td></tr><tr><td><bold>c.o.v</bold></td><td>0.0784</td><td>0.1023</td><td>0.0362</td><td>0.0156</td><td>0.0793</td><td>0.0323</td></tr><tr><td><bold>mean <italic>CCR6</italic></bold> healthy</td><td>13.3711</td><td>0.4989</td><td>3.6359</td><td>8.0667</td><td>3.5601</td><td>13.3441</td></tr><tr><td><bold>SD</bold></td><td>0.455</td><td>0.3481</td><td>0.0246</td><td>0.1585</td><td>0.1682</td><td>0.5972</td></tr><tr><td><bold>c.o.v</bold></td><td>0.034</td><td>0.6977</td><td>0.0068</td><td>0.0196</td><td>0.0472</td><td>0.0448</td></tr><tr><td><bold>mean <italic>CLEC7A</italic></bold> healthy</td><td>7.9932</td><td>22.4676</td><td>4.0984</td><td>7.9655</td><td>7.2286</td><td>7.6234</td></tr><tr><td><bold>SD</bold></td><td>0.4049</td><td>6.8424</td><td>0.1047</td><td>0.0443</td><td>1.7401</td><td>0.2268</td></tr><tr><td><bold>c.o.v</bold></td><td>0.0507</td><td>0.3045</td><td>0.0255</td><td>0.0056</td><td>0.2407</td><td>0.0298</td></tr><tr><td><bold>mean <italic>IL18</italic></bold> healthy</td><td>8.0039</td><td>15.2815</td><td>3.3938</td><td>8.6473</td><td>4.0956</td><td>7.9297</td></tr><tr><td><bold>SD</bold></td><td>0.2509</td><td>8.8324</td><td>0.16</td><td>0.5676</td><td>0.2324</td><td>0.3027</td></tr><tr><td><bold>c.o.v</bold></td><td>0.0313</td><td>0.578</td><td>0.0471</td><td>0.0656</td><td>0.0567</td><td>0.0382</td></tr><tr><td><bold>mean <italic>SRSF2</italic></bold> healthy</td><td>11.7984</td><td>121.4576</td><td>11.3332</td><td>15.0048</td><td>7.1326</td><td>12.2934</td></tr><tr><td><bold>SD</bold></td><td>0.4921</td><td>19.476</td><td>0.1832</td><td>0.9023</td><td>0.5038</td><td>0.5752</td></tr><tr><td><bold>c.o.v</bold></td><td>0.0417</td><td>0.1604</td><td>0.0162</td><td>0.0601</td><td>0.0706</td><td>0.0468</td></tr></tbody></table><table-wrap-foot><fn><p>c.o.v ​= ​coefficient of variation, SD ​= ​standard deviation, OA ​= ​osteoarthritis.</p></fn></table-wrap-foot></table-wrap><fig id="fig3"><label>Fig. 3</label><caption><p>Signature genes expression. Each tile is colored according to the gene fold change (OA vs healthy) in a specific dataset. Circle size is proportional to p-value. The dataset names (GEO IDs) are colored according to the tissue being analyzed.</p></caption><alt-text id="alttext0045">Fig. 3</alt-text><graphic xlink:href="gr3"/></fig></p>
      <p id="p0145"><underline>Hip and knee cartilage comparison.</underline> Joint-specific OA pathogenesis has been hypothesized [<xref rid="bib31" ref-type="bibr">31</xref>], but not many studies compare data from and mechanisms related to different joints [<xref rid="bib32" ref-type="bibr">[32]</xref>, <xref rid="bib33" ref-type="bibr">[33]</xref>, <xref rid="bib34" ref-type="bibr">[34]</xref>, <xref rid="bib35" ref-type="bibr">[35]</xref>, <xref rid="bib36" ref-type="bibr">[36]</xref>]. In OsteoDIP, as in the literature, most studies focus on knee, but other joints are available for comparison. For example, we compared the genes deregulated in at least one study using knee cartilage (6793 genes) and hip cartilage (1248 genes) samples. 859 genes are in common between the two sets, and include genes frequently linked to OA like OGN (the most deregulated in hip) [<xref rid="bib37" ref-type="bibr">37</xref>], TNFAIP6 (the most deregulated in knee) [<xref rid="bib38" ref-type="bibr">38</xref>], and collagen genes (COL5A1 among the most deregulated in both joints) [<xref rid="bib39" ref-type="bibr">39</xref>]. 389 genes are deregulated only in studies focused on hip cartilage, while 5936 are deregulated only in studies that focus on knee cartilage. Pathway enrichment analysis finds 1592 pathways for knee specific genes and 103 for hip specific genes. Of these, 15 pathways had no gene overlap with any other pathway for hip specific genes, while 116 pathways had no overlap for knee specific genes. No pathways were in common among the two sets. Nine of the 15 hip-specific pathways are metabolic. Metabolic differences in synovial fluid of knees and hips have been described, and in particular N-acetylated molecules, glycosaminoglycans, citrate and glutamine [<xref rid="bib35" ref-type="bibr">35</xref>]. Pathway enrichment results of non overlapping pathways are available in <xref rid="appsec1" ref-type="sec">Supplementary Table 3</xref>.</p>
      <p id="p0150"><underline>MALAT1</underline>. 786 out of 795 long non-coding RNAs present in OsteoDIP have been annotated as deregulated only in one study. Of the few long non-coding RNAs identified in multiple studies, MALAT1 is the top deregulated (three studies). We obtained experimental interactions of MALAT1, and used the target microRNAs to predict gene targets in a sequence MALAT1 → microRNA → gene. Filtering out genes absent in OsteoDIP, we created the network in <xref rid="fig4" ref-type="fig">Fig. 4</xref>: five MALAT1 targets are also targets of the microRNAs, creating regulation loops. One microRNA (hsa-miR-9-5p) is present in OsteoDIP and 4 microRNAs (hsa-miR-9-5p, hsa-miR-127–5p, hsa-miR-145–5p, hsa-miR-146–5p) have been linked in the literature to OA via MALAT1 regulation. In OA papers [<xref rid="bib40" ref-type="bibr">[40]</xref>, <xref rid="bib41" ref-type="bibr">[41]</xref>, <xref rid="bib42" ref-type="bibr">[42]</xref>, <xref rid="bib43" ref-type="bibr">[43]</xref>, <xref rid="bib44" ref-type="bibr">[44]</xref>, <xref rid="bib45" ref-type="bibr">[45]</xref>] [<xref rid="bib40" ref-type="bibr">[40]</xref>, <xref rid="bib41" ref-type="bibr">[41]</xref>, <xref rid="bib42" ref-type="bibr">[42]</xref>, <xref rid="bib43" ref-type="bibr">[43]</xref>, <xref rid="bib44" ref-type="bibr">[44]</xref>, <xref rid="bib45" ref-type="bibr">[45]</xref>] [<xref rid="bib40" ref-type="bibr">[40]</xref>, <xref rid="bib41" ref-type="bibr">[41]</xref>, <xref rid="bib42" ref-type="bibr">[42]</xref>, <xref rid="bib43" ref-type="bibr">[43]</xref>, <xref rid="bib44" ref-type="bibr">[44]</xref>, <xref rid="bib45" ref-type="bibr">[45]</xref>], MALAT1 is shown to affect proliferation as well as ECM degradation. Pathway enrichment analysis of OsteoDIP targets of the 4 microRNA finds 27 enriched pathways, mainly linked to ECM, collagen formation and degradation and integrin signaling (available in <xref rid="appsec1" ref-type="sec">Supplementary Table 4</xref>).<fig id="fig4"><label>Fig. 4</label><caption><p>MALAT1 network. MALAT1:target interactions are collected from LncTarD, while microRNA:gene ones are obtained from mirDIP. Blue nodes show microRNAs, while blue outline shows MALAT1 targets described in the literature as linked to OA. Blue edges illustrate the interactions between these microRNAs and their targets. Gene targets of the OA linked microRNAs are color coded according to the pathway with the lowest p-value they belong to.</p></caption><alt-text id="alttext0050">Fig. 4</alt-text><graphic xlink:href="gr4"/></fig></p>
    </sec>
  </sec>
  <sec id="sec4">
    <label>4</label>
    <title>Discussion</title>
    <p id="p0155">Data curation provides a scientific asset to any research topic, but curation remains challenging due to frequent data unavailability, missing and limited clinical and biological annotation, limited biological assays or improper informatics workflows [<xref rid="bib46" ref-type="bibr">46</xref>]. In OA many high-throughput studies have been and are being conducted to identify molecular pathogenesis paths, characterize patient heterogeneity and predict new (and effective) OA treatments. One feature of high-throughput studies is the amount of data collected – it being related to any set of molecules (i.e., the entire genome, the entire proteome, the entire transcriptome, metabolome). Obtaining high throughput data is expensive, though, leading to the application of these methods to only a reduced number of patient samples. While these data are still valuable, patient heterogeneity, lack of standard formats and annotation for data release (when available), different assays, and different questions being investigated can impede comparisons across studies. Still, each study provides a step to get closer to a more complete picture of OA molecular background, patient subtyping, and precision treatment.</p>
    <p id="p0160">One aim of data curation is to collect and integrate multiple datasets that are scattered across different locations (such as different databases or, as in our case, different publications), and annotate them with the same ontology and rigour. To satisfy this aim, we curated and collected all available literature on gene expression studies, and we curated the most recent studies on non-coding RNA expression. A second aim of data curation is to consolidate the data so that it is comparable across studies and, if possible, patients, and to annotate it with relevant information, such as tissue, disease, interactions and pathways. To this aim, all the data collected have been annotated with standard labels so that it is easily searchable but also, being structured data, amenable to computational analyses.</p>
    <p id="p0165">As highlighted with examples and use cases, OsteoDIP can support diverse translational research projects in OA. If a researcher has already identified molecules of interest (as in the microRNA example), OsteoDIP can provide the researcher with literature and multiple annotations for protein coding genes – all in one database. Such annotations can assist with simple tasks, e.g., providing context for genes of interest, or can provide the basis for further research steps. For example, knowing what part of a PPI network involving the proteins of interest is conserved across species (and which species) can suggest the best animal model where to test a specific mechanism, investigate OA pathogenesis or validate a hypothesized treatment. It is well known that there is not a single animal model that mimics all molecular and clinicopathological aspects of human OA (or indeed any complex disease), and that different models need to be used to answer different questions [<xref rid="bib47" ref-type="bibr">47</xref>]. Thus, it would be useful to predict beforehand which model organism best recapitulates relevant biological context required for <italic>in vivo</italic> studies and pre-clinical validation.</p>
    <p id="p0170">Some genes of interest could be queried across different datasets and their gene expression compared (as in the signature genes examples). If needed, the expression could be linked to structured clinical data to provide support for external validations, reducing the time a researcher would need to spend to find the same type of data in more generic data repositories – and the time needed to consolidate the data that, due to lack of standard labels in many databases, is usually quite different from one dataset to another. In our example, we attempted to link genes present in an OA diagnostic blood signature to a possible OA mechanism in other tissues, but other researchers could be interested in using the same data to investigate and validate prognostic or predictive signature performance. Most gene expression signatures do not generalize to new data; over 150,000 studies have reported gene signatures, but fewer than 100 are in clinical use [<xref rid="bib48" ref-type="bibr">48</xref>]. The best way to find an effective signature is to validate its performance across many independent datasets. Such testing and analysis can answer several key questions about a candidate signature: does the signature reflect biological mechanisms or technical artifacts, does it work across independent cohorts, and if not, does it work in specific subsets of samples. Testing a signature in more than one dataset greatly reduces the chances that it is based on technical artifacts, such as a protocol for gathering or processing data. Testing on many datasets with heterogenous samples, including different age groups and both sexes, can indicate whether the signature can easily generalize to new cohorts. A signature may not work in all datasets, because many datasets include multiple conditions, such disease status, drug treatments and comorbidities, that all greatly affect gene expression. It is also important to pay attention to sample independence, that can strongly affect the results obtained. If a signature works in at least a few datasets, it may be possible to determine the context where the signature is effective; but it is equally valuable to know which patient cohorts cannot be reliably analyzed due to signature bias.</p>
    <p id="p0175">Finally, researchers that have OA molecular questions but no genes to start with, could query OsteoDIP and identify genes frequently associated with a feature of interest, or compare genes associated with different characteristic (as in the joint specific OA and the top deregulated genes examples).</p>
    <p id="p0180">We designed OsteoDIP to be flexible, so that many types of searches could be performed, open access, so that any kind of data collected and stored in OsteoDIP is immediately available to researchers, and modular, so that any kind of data of interest for the OA community can be included and the types of curation provided expanded.</p>
  </sec>
  <sec id="sec5">
    <title>Author contribution</title>
    <p id="p0185">CP participated in conception and design of the study, curated the data, performed analyses and data interpretation, drafted the article, and approved the final version of the manuscript. MA and RL created and update the database, collected annotation data, update nomenclature, drafted the article, and approved the final version of the manuscript. ZA collected and normalized GEO data, revised critically the article, and approved the final version of the manuscript. MK provided PPI conservation data, participated in data analysis and interpretation, revised critically the article, and approved the final version of the manuscript. CV participated in conception and design of the study, revised critically the article, obtained funding, and approved the final version of the manuscript. IJ (<ext-link ext-link-type="uri" xlink:href="mailto:juris@ai.utoronto.ca" id="intref0055">juris@ai.utoronto.ca</ext-link>) participated in conception and design of the study, obtained funding, revised critically the article, approved the final version of the manuscript, and take responsibility for the integrity of the work as a whole, from inception to finished article.</p>
  </sec>
  <sec id="sec6">
    <title>Role of the funding source</title>
    <p id="p0190">This work was in part supported by the <funding-source id="gs15">Krembil Research Foundation</funding-source> (grant to CV and IJ), Schroeder Arthritis Institute via the <funding-source id="gs6"><institution-wrap><institution-id institution-id-type="doi">10.13039/100012456</institution-id><institution>Toronto General and Western Hospital Foundation</institution></institution-wrap></funding-source>, <funding-source id="gs7"><institution-wrap><institution-id institution-id-type="doi">10.13039/100009663</institution-id><institution>University Health Network</institution></institution-wrap></funding-source>. IJ was supported in part by funding from <funding-source id="gs8"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100000038</institution-id><institution>Natural Sciences Research Council</institution></institution-wrap></funding-source> (NSERC #203475), <funding-source id="gs9">Canada Foundation for Innovation</funding-source> (CFI #225404, #30865), Ontario Research Fund (<funding-source id="gs11"><institution-wrap><institution-id institution-id-type="doi">10.13039/100006529</institution-id><institution>RDI</institution></institution-wrap></funding-source> #34876), Buchan Foundation, Ian Lawson van Toch Fund and <funding-source id="gs14"><institution-wrap><institution-id institution-id-type="doi">10.13039/100004316</institution-id><institution>IBM</institution></institution-wrap></funding-source>.</p>
    <p id="p0195">The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>Declaration of competing interest</title>
    <p id="p0205">At the end of the text, under a subheading “Conflict of interest statement” all authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and research grants or other funding.</p>
  </sec>
</body>
<back>
  <ref-list id="cebib0010">
    <title>References</title>
    <ref id="bib1">
      <label>1</label>
      <element-citation publication-type="journal" id="sref1">
        <person-group person-group-type="author">
          <name>
            <surname>Cantini</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Calzone</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Martignetti</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Rydenfelt</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Blüthgen</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Barillot</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Zinovyev</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>Classification of gene signatures for their information value and functional redundancy</article-title>
        <source>Npj Syst. Biol. Appl.</source>
        <volume>4</volume>
        <year>2018</year>
        <fpage>2</fpage>
        <pub-id pub-id-type="doi">10.1038/s41540-017-0038-8</pub-id>
        <pub-id pub-id-type="pmid">29263798</pub-id>
      </element-citation>
    </ref>
    <ref id="bib2">
      <label>2</label>
      <element-citation publication-type="journal" id="sref2">
        <person-group person-group-type="author">
          <name>
            <surname>Cerami</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Dogrusoz</surname>
            <given-names>U.</given-names>
          </name>
          <name>
            <surname>Gross</surname>
            <given-names>B.E.</given-names>
          </name>
          <name>
            <surname>Sumer</surname>
            <given-names>S.O.</given-names>
          </name>
          <name>
            <surname>Aksoy</surname>
            <given-names>B.A.</given-names>
          </name>
          <name>
            <surname>Jacobsen</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Byrne</surname>
            <given-names>C.J.</given-names>
          </name>
          <name>
            <surname>Heuer</surname>
            <given-names>M.L.</given-names>
          </name>
          <name>
            <surname>Larsson</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Antipin</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Reva</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Goldberg</surname>
            <given-names>A.P.</given-names>
          </name>
          <name>
            <surname>Sander</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Schultz</surname>
            <given-names>N.</given-names>
          </name>
        </person-group>
        <article-title>The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data</article-title>
        <source>Cancer Discov.</source>
        <volume>2</volume>
        <year>2012</year>
        <fpage>401</fpage>
        <lpage>404</lpage>
        <pub-id pub-id-type="doi">10.1158/2159-8290.CD-12-0095</pub-id>
        <pub-id pub-id-type="pmid">22588877</pub-id>
      </element-citation>
    </ref>
    <ref id="bib3">
      <label>3</label>
      <element-citation publication-type="journal" id="sref3">
        <person-group person-group-type="author">
          <name>
            <surname>Ruiz-Romero</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Rego-Perez</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Blanco</surname>
            <given-names>F.J.</given-names>
          </name>
        </person-group>
        <article-title>What did we learn from “omics” studies in osteoarthritis</article-title>
        <source>Curr. Opin. Rheumatol.</source>
        <volume>30</volume>
        <year>2018</year>
        <fpage>114</fpage>
        <lpage>120</lpage>
        <pub-id pub-id-type="doi">10.1097/BOR.0000000000000460</pub-id>
        <pub-id pub-id-type="pmid">29035928</pub-id>
      </element-citation>
    </ref>
    <ref id="bib4">
      <label>4</label>
      <element-citation publication-type="journal" id="sref4">
        <person-group person-group-type="author">
          <name>
            <surname>Soul</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Hardingham</surname>
            <given-names>T.E.</given-names>
          </name>
          <name>
            <surname>Boot-Handford</surname>
            <given-names>R.P.</given-names>
          </name>
          <name>
            <surname>Schwartz</surname>
            <given-names>J.-M.</given-names>
          </name>
        </person-group>
        <article-title>SkeletalVis: an exploration and meta-analysis data portal of cross-species skeletal transcriptomics data</article-title>
        <source>Bioinformatics</source>
        <volume>35</volume>
        <year>2019</year>
        <fpage>2283</fpage>
        <lpage>2290</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bty947</pub-id>
        <pub-id pub-id-type="pmid">30481257</pub-id>
      </element-citation>
    </ref>
    <ref id="bib5">
      <label>5</label>
      <element-citation publication-type="journal" id="sref5">
        <person-group person-group-type="author">
          <name>
            <surname>Soul</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Barter</surname>
            <given-names>M.J.</given-names>
          </name>
          <name>
            <surname>Little</surname>
            <given-names>C.B.</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>D.A.</given-names>
          </name>
        </person-group>
        <article-title>OATargets: a knowledge base of genes associated with osteoarthritis joint damage in animals</article-title>
        <source>Ann. Rheum. Dis.</source>
        <volume>80</volume>
        <year>2020</year>
        <fpage>376</fpage>
        <lpage>383</lpage>
        <pub-id pub-id-type="doi">10.1136/annrheumdis-2020-218344</pub-id>
        <pub-id pub-id-type="pmid">33077471</pub-id>
      </element-citation>
    </ref>
    <ref id="bib6">
      <label>6</label>
      <element-citation publication-type="journal" id="sref6">
        <person-group person-group-type="author">
          <name>
            <surname>Ratneswaran</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Kapoor</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Osteoarthritis year in review: genetics, genomics, epigenetics</article-title>
        <source>Osteoarthritis Cartilage</source>
        <volume>29</volume>
        <year>2021</year>
        <fpage>151</fpage>
        <lpage>160</lpage>
        <pub-id pub-id-type="doi">10.1016/j.joca.2020.11.003</pub-id>
        <pub-id pub-id-type="pmid">33227439</pub-id>
      </element-citation>
    </ref>
    <ref id="bib7">
      <label>7</label>
      <element-citation publication-type="journal" id="sref7">
        <person-group person-group-type="author">
          <name>
            <surname>Tweedie</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Braschi</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Gray</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Jones</surname>
            <given-names>T.E.M.</given-names>
          </name>
          <name>
            <surname>Seal</surname>
            <given-names>R.L.</given-names>
          </name>
          <name>
            <surname>Yates</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Bruford</surname>
            <given-names>E.A.</given-names>
          </name>
        </person-group>
        <article-title>Genenames.org: the HGNC and VGNC resources in 2021</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>49</volume>
        <year>2021</year>
        <fpage>D939</fpage>
        <lpage>D946</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa980</pub-id>
        <pub-id pub-id-type="pmid">33152070</pub-id>
      </element-citation>
    </ref>
    <ref id="bib8">
      <label>8</label>
      <element-citation publication-type="journal" id="sref8">
        <person-group person-group-type="author">
          <name>
            <surname>Kozomara</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Birgaoanu</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Griffiths-Jones</surname>
            <given-names>S.</given-names>
          </name>
        </person-group>
        <article-title>miRBase: from microRNA sequences to function</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>47</volume>
        <year>2019</year>
        <pub-id pub-id-type="doi">10.1093/nar/gky1141</pub-id>
        <comment>D155–D162</comment>
      </element-citation>
    </ref>
    <ref id="bib9">
      <label>9</label>
      <element-citation publication-type="journal" id="sref9">
        <person-group person-group-type="author">
          <name>
            <surname>Volders</surname>
            <given-names>P.-J.</given-names>
          </name>
          <name>
            <surname>Anckaert</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Verheggen</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Nuytens</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Martens</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Mestdagh</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Vandesompele</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <article-title>LNCipedia 5: towards a reference set of human long non-coding RNAs</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>47</volume>
        <year>2019</year>
        <pub-id pub-id-type="doi">10.1093/nar/gky1031</pub-id>
        <comment>D135–D139</comment>
      </element-citation>
    </ref>
    <ref id="bib10">
      <label>10</label>
      <element-citation publication-type="journal" id="sref10">
        <person-group person-group-type="author">
          <name>
            <surname>Edgar</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Domrachev</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Lash</surname>
            <given-names>A.E.</given-names>
          </name>
        </person-group>
        <article-title>Gene Expression Omnibus: NCBI gene expression and hybridization array data repository</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>30</volume>
        <year>2002</year>
        <fpage>207</fpage>
        <lpage>210</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/30.1.207</pub-id>
        <pub-id pub-id-type="pmid">11752295</pub-id>
      </element-citation>
    </ref>
    <ref id="bib11">
      <label>11</label>
      <element-citation publication-type="book" id="sref11">
        <person-group person-group-type="author">
          <collab>R Core Team</collab>
          <name>
            <surname>Language</surname>
            <given-names>R.A.</given-names>
          </name>
        </person-group>
        <part-title>And Environment for Statistical Computing</part-title>
        <year>2014</year>
        <ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/" id="intref0065">http://www.r-project.org/</ext-link>
      </element-citation>
    </ref>
    <ref id="bib12">
      <label>12</label>
      <element-citation publication-type="journal" id="sref12">
        <person-group person-group-type="author">
          <name>
            <surname>Ritchie</surname>
            <given-names>M.E.</given-names>
          </name>
          <name>
            <surname>Phipson</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Law</surname>
            <given-names>C.W.</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Smyth</surname>
            <given-names>G.K.</given-names>
          </name>
        </person-group>
        <article-title>Limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>43</volume>
        <year>2015</year>
        <fpage>e47</fpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id>
        <pub-id pub-id-type="pmid">25605792</pub-id>
      </element-citation>
    </ref>
    <ref id="bib13">
      <label>13</label>
      <element-citation publication-type="journal" id="sref13">
        <person-group person-group-type="author">
          <name>
            <surname>Gautier</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Cope</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Bolstad</surname>
            <given-names>B.M.</given-names>
          </name>
          <name>
            <surname>Irizarry</surname>
            <given-names>R.A.</given-names>
          </name>
        </person-group>
        <article-title>affy--analysis of Affymetrix GeneChip data at the probe level</article-title>
        <source>Bioinformatics</source>
        <volume>20</volume>
        <year>2004</year>
        <fpage>307</fpage>
        <lpage>315</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btg405</pub-id>
        <pub-id pub-id-type="pmid">14960456</pub-id>
      </element-citation>
    </ref>
    <ref id="bib14">
      <label>14</label>
      <element-citation publication-type="journal" id="sref14">
        <person-group person-group-type="author">
          <name>
            <surname>Carvalho</surname>
            <given-names>B.S.</given-names>
          </name>
          <name>
            <surname>Irizarry</surname>
            <given-names>R.A.</given-names>
          </name>
        </person-group>
        <article-title>A framework for oligonucleotide microarray preprocessing</article-title>
        <source>Bioinformatics</source>
        <volume>26</volume>
        <year>2010</year>
        <fpage>2363</fpage>
        <lpage>2367</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btq431</pub-id>
        <pub-id pub-id-type="pmid">20688976</pub-id>
      </element-citation>
    </ref>
    <ref id="bib15">
      <label>15</label>
      <element-citation publication-type="journal" id="sref15">
        <person-group person-group-type="author">
          <name>
            <surname>Piñero</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Ramírez-Anguita</surname>
            <given-names>J.M.</given-names>
          </name>
          <name>
            <surname>Saüch-Pitarch</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Ronzano</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Centeno</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Sanz</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Furlong</surname>
            <given-names>L.I.</given-names>
          </name>
        </person-group>
        <article-title>The DisGeNET knowledge platform for disease genomics: 2019 update</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>48</volume>
        <year>2019</year>
        <fpage>D845</fpage>
        <lpage>D855</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkz1021</pub-id>
      </element-citation>
    </ref>
    <ref id="bib16">
      <label>16</label>
      <element-citation publication-type="journal" id="sref16">
        <person-group person-group-type="author">
          <name>
            <surname>Uhlén</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Karlsson</surname>
            <given-names>M.J.</given-names>
          </name>
          <name>
            <surname>Hober</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Svensson</surname>
            <given-names>A.-S.</given-names>
          </name>
          <name>
            <surname>Scheffel</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Kotol</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Zhong</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Tebani</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Strandberg</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Edfors</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Sjöstedt</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Mulder</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Mardinoglu</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Berling</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Ekblad</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Dannemeyer</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Kanje</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Rockberg</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Lundqvist</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Malm</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Volk</surname>
            <given-names>A.-L.</given-names>
          </name>
          <name>
            <surname>Nilsson</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Månberg</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Dodig-Crnkovic</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Pin</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Zwahlen</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Oksvold</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>von Feilitzen</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Häussler</surname>
            <given-names>R.S.</given-names>
          </name>
          <name>
            <surname>Hong</surname>
            <given-names>M.-G.</given-names>
          </name>
          <name>
            <surname>Lindskog</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Ponten</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Katona</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Vuu</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Lindström</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Nielsen</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Robinson</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Ayoglu</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Mahdessian</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Sullivan</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Thul</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Danielsson</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Stadler</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Lundberg</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Bergström</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Gummesson</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Voldborg</surname>
            <given-names>B.G.</given-names>
          </name>
          <name>
            <surname>Tegel</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Hober</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Forsström</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Schwenk</surname>
            <given-names>J.M.</given-names>
          </name>
          <name>
            <surname>Fagerberg</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Sivertsson</surname>
            <given-names>Å.</given-names>
          </name>
        </person-group>
        <article-title>The human secretome</article-title>
        <source>Sci. Signal.</source>
        <volume>12</volume>
        <year>2019</year>
        <pub-id pub-id-type="doi">10.1126/scisignal.aaz0274</pub-id>
      </element-citation>
    </ref>
    <ref id="bib17">
      <label>17</label>
      <element-citation publication-type="journal" id="sref17">
        <person-group person-group-type="author">
          <name>
            <surname>Meinken</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Walker</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Cooper</surname>
            <given-names>C.R.</given-names>
          </name>
          <name>
            <surname>Min</surname>
            <given-names>X.J.</given-names>
          </name>
        </person-group>
        <article-title>MetazSecKB: the Human and Animal Secretome and Subcellular Proteome Knowledgebase</article-title>
        <source>Database</source>
        <year>2015</year>
        <pub-id pub-id-type="doi">10.1093/database/bav077</pub-id>
        <comment>2015</comment>
      </element-citation>
    </ref>
    <ref id="bib18">
      <label>18</label>
      <element-citation publication-type="journal" id="sref18">
        <person-group person-group-type="author">
          <name>
            <surname>Buniello</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>MacArthur</surname>
            <given-names>J.A.L.</given-names>
          </name>
          <name>
            <surname>Cerezo</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Harris</surname>
            <given-names>L.W.</given-names>
          </name>
          <name>
            <surname>Hayhurst</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Malangone</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>McMahon</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Morales</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Mountjoy</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Sollis</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Suveges</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Vrousgou</surname>
            <given-names>O.</given-names>
          </name>
          <name>
            <surname>Whetzel</surname>
            <given-names>P.L.</given-names>
          </name>
          <name>
            <surname>Amode</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Guillen</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>Riat</surname>
            <given-names>H.S.</given-names>
          </name>
          <name>
            <surname>Trevanion</surname>
            <given-names>S.J.</given-names>
          </name>
          <name>
            <surname>Hall</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Junkins</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Flicek</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Burdett</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Hindorff</surname>
            <given-names>L.A.</given-names>
          </name>
          <name>
            <surname>Cunningham</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Parkinson</surname>
            <given-names>H.</given-names>
          </name>
        </person-group>
        <article-title>The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>47</volume>
        <year>2019</year>
        <fpage>D1005</fpage>
        <lpage>D1012</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1120</pub-id>
        <pub-id pub-id-type="pmid">30445434</pub-id>
      </element-citation>
    </ref>
    <ref id="bib19">
      <label>19</label>
      <element-citation publication-type="journal" id="sref19">
        <person-group person-group-type="author">
          <name>
            <surname>Kotlyar</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Pastrello</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Malik</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Jurisica</surname>
            <given-names>I.</given-names>
          </name>
        </person-group>
        <article-title>IID 2018 update: context-specific physical protein-protein interactions in human, model organisms and domesticated species</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>47</volume>
        <year>2019</year>
        <fpage>D581</fpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1037</pub-id>
        <comment>–D589</comment>
        <pub-id pub-id-type="pmid">30407591</pub-id>
      </element-citation>
    </ref>
    <ref id="bib20">
      <label>20</label>
      <element-citation publication-type="journal" id="sref20">
        <person-group person-group-type="author">
          <name>
            <surname>Yates</surname>
            <given-names>A.D.</given-names>
          </name>
          <name>
            <surname>Achuthan</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Akanni</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Allen</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Allen</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Alvarez-Jarreta</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Amode</surname>
            <given-names>M.R.</given-names>
          </name>
          <name>
            <surname>Armean</surname>
            <given-names>I.M.</given-names>
          </name>
          <name>
            <surname>Azov</surname>
            <given-names>A.G.</given-names>
          </name>
          <name>
            <surname>Bennett</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Bhai</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Billis</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Boddu</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Marugán</surname>
            <given-names>J.C.</given-names>
          </name>
          <name>
            <surname>Cummins</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Davidson</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Dodiya</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Fatima</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Gall</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Giron</surname>
            <given-names>C.G.</given-names>
          </name>
          <name>
            <surname>Gil</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Grego</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Haggerty</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Haskell</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Hourlier</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Izuogu</surname>
            <given-names>O.G.</given-names>
          </name>
          <name>
            <surname>Janacek</surname>
            <given-names>S.H.</given-names>
          </name>
          <name>
            <surname>Juettemann</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Kay</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Lavidas</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Le</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Lemos</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Martinez</surname>
            <given-names>J.G.</given-names>
          </name>
          <name>
            <surname>Maurel</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>McDowall</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>McMahon</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Mohanan</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Moore</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Nuhn</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Oheh</surname>
            <given-names>D.N.</given-names>
          </name>
          <name>
            <surname>Parker</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Parton</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Patricio</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Sakthivel</surname>
            <given-names>M.P.</given-names>
          </name>
          <name>
            <surname>Abdul Salam</surname>
            <given-names>A.I.</given-names>
          </name>
          <name>
            <surname>Schmitt</surname>
            <given-names>B.M.</given-names>
          </name>
          <name>
            <surname>Schuilenburg</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Sheppard</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Sycheva</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Szuba</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Thormann</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Threadgold</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Vullo</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Walts</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Winterbottom</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Zadissa</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Chakiachvili</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Flint</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Frankish</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Hunt</surname>
            <given-names>S.E.</given-names>
          </name>
          <name>
            <surname>IIsley</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Kostadima</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Langridge</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Loveland</surname>
            <given-names>J.E.</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>F.J.</given-names>
          </name>
          <name>
            <surname>Morales</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Mudge</surname>
            <given-names>J.M.</given-names>
          </name>
          <name>
            <surname>Muffato</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Perry</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Ruffier</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Trevanion</surname>
            <given-names>S.J.</given-names>
          </name>
          <name>
            <surname>Cunningham</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Howe</surname>
            <given-names>K.L.</given-names>
          </name>
          <name>
            <surname>Zerbino</surname>
            <given-names>D.R.</given-names>
          </name>
          <name>
            <surname>Flicek</surname>
            <given-names>P.</given-names>
          </name>
        </person-group>
        <article-title>Ensembl 2020</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>48</volume>
        <year>2020</year>
        <fpage>D682</fpage>
        <lpage>D688</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkz966</pub-id>
        <pub-id pub-id-type="pmid">31691826</pub-id>
      </element-citation>
    </ref>
    <ref id="bib21">
      <label>21</label>
      <element-citation publication-type="journal" id="sref21">
        <person-group person-group-type="author">
          <name>
            <surname>Tokar</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Pastrello</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Rossos</surname>
            <given-names>A.E.M.</given-names>
          </name>
          <name>
            <surname>Abovsky</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Hauschild</surname>
            <given-names>A.-C.</given-names>
          </name>
          <name>
            <surname>Tsay</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Jurisica</surname>
            <given-names>I.</given-names>
          </name>
        </person-group>
        <article-title>mirDIP 4.1-integrative database of human microRNA target predictions</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>46</volume>
        <year>2018</year>
        <fpage>D360</fpage>
        <lpage>D370</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1144</pub-id>
        <pub-id pub-id-type="pmid">29194489</pub-id>
      </element-citation>
    </ref>
    <ref id="bib22">
      <label>22</label>
      <element-citation publication-type="journal" id="sref22">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Qiu</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>W.</given-names>
          </name>
        </person-group>
        <article-title>A four-genes based diagnostic signature for osteoarthritis</article-title>
        <source>Rheumatol. Int.</source>
        <year>2021</year>
        <fpage>1</fpage>
        <lpage>9</lpage>
        <pub-id pub-id-type="doi">10.1007/s00296-021-04795-6</pub-id>
      </element-citation>
    </ref>
    <ref id="bib24">
      <label>24</label>
      <element-citation publication-type="journal" id="sref24">
        <person-group person-group-type="author">
          <name>
            <surname>Endisha</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Rockel</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Jurisica</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Kapoor</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>The complex landscape of microRNAs in articular cartilage: biology, pathology, and therapeutic targets</article-title>
        <source>JCI Insight</source>
        <volume>3</volume>
        <year>2018</year>
        <pub-id pub-id-type="doi">10.1172/JCI.INSIGHT.121630</pub-id>
      </element-citation>
    </ref>
    <ref id="bib25">
      <label>25</label>
      <element-citation publication-type="journal" id="sref25">
        <person-group person-group-type="author">
          <name>
            <surname>Djebbari</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Ali</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Otasek</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Kotlyar</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Fortney</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Wong</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Hrvojic</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Jurisica</surname>
            <given-names>I.</given-names>
          </name>
        </person-group>
        <article-title>NAViGaTOR: large scalable and interactive navigation and analysis of large graphs</article-title>
        <source>Internet Math.</source>
        <volume>7</volume>
        <year>2011</year>
        <fpage>314</fpage>
        <lpage>347</lpage>
        <pub-id pub-id-type="doi">10.1080/15427951.2011.604289</pub-id>
      </element-citation>
    </ref>
    <ref id="bib26">
      <label>26</label>
      <element-citation publication-type="journal" id="sref26">
        <person-group person-group-type="author">
          <name>
            <surname>Rahmati</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Abovsky</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Pastrello</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Kotlyar</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Cumbaa</surname>
            <given-names>C.A.</given-names>
          </name>
          <name>
            <surname>Rahman</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Chandran</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Jurisica</surname>
            <given-names>I.</given-names>
          </name>
        </person-group>
        <article-title>pathDIP 4: an extended pathway annotations and enrichment analysis resource for human, model organisms and domesticated species</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>48</volume>
        <year>2019</year>
        <fpage>D479</fpage>
        <lpage>D488</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkz989</pub-id>
      </element-citation>
    </ref>
    <ref id="bib27">
      <label>27</label>
      <element-citation publication-type="journal" id="sref27">
        <person-group person-group-type="author">
          <name>
            <surname>Zhao</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Lei</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Leng</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Xiao</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X.</given-names>
          </name>
        </person-group>
        <article-title>LncTarD: a manually-curated database of experimentally-supported functional lncRNA–target regulations in human diseases</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>48</volume>
        <year>2019</year>
        <fpage>D118</fpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkz985</pub-id>
        <comment>–D126</comment>
      </element-citation>
    </ref>
    <ref id="bib28">
      <label>28</label>
      <element-citation publication-type="journal" id="sref28">
        <person-group person-group-type="author">
          <name>
            <surname>Zhao</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Su</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>You</surname>
            <given-names>Q.</given-names>
          </name>
        </person-group>
        <article-title>Chitinase-3 like-protein-1 function and its role in diseases</article-title>
        <source>Signal Transduct. Target. Ther.</source>
        <volume>5</volume>
        <year>2020</year>
        <fpage>201</fpage>
        <pub-id pub-id-type="doi">10.1038/s41392-020-00303-7</pub-id>
        <pub-id pub-id-type="pmid">32929074</pub-id>
      </element-citation>
    </ref>
    <ref id="bib29">
      <label>29</label>
      <element-citation publication-type="journal" id="sref29">
        <person-group person-group-type="author">
          <name>
            <surname>Gao</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Du</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Ke</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X.</given-names>
          </name>
        </person-group>
        <article-title>KLF2 protects against osteoarthritis by repressing oxidative response through activation of Nrf2/ARE signaling <italic>in vitro</italic> and <italic>in vivo</italic></article-title>
        <source>Oxid. Med. Cell. Longev.</source>
        <year>2019</year>
        <fpage>1</fpage>
        <lpage>18</lpage>
        <pub-id pub-id-type="doi">10.1155/2019/8564681</pub-id>
        <comment>(2019)</comment>
      </element-citation>
    </ref>
    <ref id="bib31">
      <label>31</label>
      <element-citation publication-type="journal" id="sref31">
        <person-group person-group-type="author">
          <name>
            <surname>Meliconi</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Pulsatelli</surname>
            <given-names>L.</given-names>
          </name>
        </person-group>
        <article-title>Are mechanisms of inflammation joint-specific in osteoarthritis?</article-title>
        <source>Rheumatology</source>
        <volume>58</volume>
        <year>2019</year>
        <fpage>743</fpage>
        <lpage>745</lpage>
        <pub-id pub-id-type="doi">10.1093/rheumatology/key300</pub-id>
        <pub-id pub-id-type="pmid">30304502</pub-id>
      </element-citation>
    </ref>
    <ref id="bib32">
      <label>32</label>
      <element-citation publication-type="journal" id="sref32">
        <person-group person-group-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Barter</surname>
            <given-names>M.J.</given-names>
          </name>
          <name>
            <surname>Swan</surname>
            <given-names>D.C.</given-names>
          </name>
          <name>
            <surname>Rankin</surname>
            <given-names>K.S.</given-names>
          </name>
          <name>
            <surname>Rowan</surname>
            <given-names>A.D.</given-names>
          </name>
          <name>
            <surname>Santibanez-Koref</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Loughlin</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>D.A.</given-names>
          </name>
        </person-group>
        <article-title>Identification of the pathogenic pathways in osteoarthritic hip cartilage: commonality and discord between hip and knee OA</article-title>
        <source>Osteoarthritis Cartilage</source>
        <volume>20</volume>
        <year>2012</year>
        <fpage>1029</fpage>
        <lpage>1038</lpage>
        <pub-id pub-id-type="doi">10.1016/j.joca.2012.05.006</pub-id>
        <pub-id pub-id-type="pmid">22659600</pub-id>
      </element-citation>
    </ref>
    <ref id="bib33">
      <label>33</label>
      <element-citation publication-type="journal" id="sref33">
        <person-group person-group-type="author">
          <name>
            <surname>Barreto</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Sandelin</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Salem</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Nordström</surname>
            <given-names>D.C.</given-names>
          </name>
          <name>
            <surname>Waris</surname>
            <given-names>E.</given-names>
          </name>
        </person-group>
        <article-title>Toll-like receptors and their soluble forms differ in the knee and thumb basal osteoarthritic joints</article-title>
        <source>Acta Orthop.</source>
        <volume>88</volume>
        <year>2017</year>
        <fpage>326</fpage>
        <lpage>333</lpage>
        <pub-id pub-id-type="doi">10.1080/17453674.2017.1281058</pub-id>
        <pub-id pub-id-type="pmid">28093922</pub-id>
      </element-citation>
    </ref>
    <ref id="bib34">
      <label>34</label>
      <element-citation publication-type="journal" id="sref34">
        <person-group person-group-type="author">
          <name>
            <surname>Barreto</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Soliymani</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Baumann</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Waris</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Eklund</surname>
            <given-names>K.K.</given-names>
          </name>
          <name>
            <surname>Zenobi-Wong</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Lalowski</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Functional analysis of synovial fluid from osteoarthritic knee and carpometacarpal joints unravels different molecular profiles</article-title>
        <source>Rheumatology</source>
        <volume>58</volume>
        <year>2019</year>
        <fpage>897</fpage>
        <lpage>907</lpage>
        <pub-id pub-id-type="doi">10.1093/rheumatology/key232</pub-id>
        <pub-id pub-id-type="pmid">30085131</pub-id>
      </element-citation>
    </ref>
    <ref id="bib35">
      <label>35</label>
      <element-citation publication-type="journal" id="sref35">
        <person-group person-group-type="author">
          <name>
            <surname>Akhbari</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Jaggard</surname>
            <given-names>M.K.</given-names>
          </name>
          <name>
            <surname>Boulangé</surname>
            <given-names>C.L.</given-names>
          </name>
          <name>
            <surname>Vaghela</surname>
            <given-names>U.</given-names>
          </name>
          <name>
            <surname>Graça</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Bhattacharya</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Lindon</surname>
            <given-names>J.C.</given-names>
          </name>
          <name>
            <surname>Williams</surname>
            <given-names>H.R.T.</given-names>
          </name>
          <name>
            <surname>Gupte</surname>
            <given-names>C.M.</given-names>
          </name>
        </person-group>
        <article-title>Differences in the composition of hip and knee synovial fluid in osteoarthritis: a nuclear magnetic resonance (NMR) spectroscopy study of metabolic profiles</article-title>
        <source>Osteoarthritis Cartilage</source>
        <volume>27</volume>
        <year>2019</year>
        <fpage>1768</fpage>
        <lpage>1777</lpage>
        <pub-id pub-id-type="doi">10.1016/j.joca.2019.07.017</pub-id>
        <pub-id pub-id-type="pmid">31491490</pub-id>
      </element-citation>
    </ref>
    <ref id="bib36">
      <label>36</label>
      <element-citation publication-type="journal" id="sref36">
        <person-group person-group-type="author">
          <name>
            <surname>den Hollander</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Ramos</surname>
            <given-names>Y.F.M.</given-names>
          </name>
          <name>
            <surname>Bos</surname>
            <given-names>S.D.</given-names>
          </name>
          <name>
            <surname>Bomer</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>van der Breggen</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Lakenberg</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>de Dijcker</surname>
            <given-names>W.J.</given-names>
          </name>
          <name>
            <surname>Duijnisveld</surname>
            <given-names>B.J.</given-names>
          </name>
          <name>
            <surname>Slagboom</surname>
            <given-names>P.E.</given-names>
          </name>
          <name>
            <surname>Nelissen</surname>
            <given-names>R.G.H.H.</given-names>
          </name>
          <name>
            <surname>Meulenbelt</surname>
            <given-names>I.</given-names>
          </name>
        </person-group>
        <article-title>Knee and hip articular cartilage have distinct epigenomic landscapes: implications for future cartilage regeneration approaches</article-title>
        <source>Ann. Rheum. Dis.</source>
        <volume>73</volume>
        <year>2014</year>
        <fpage>2208</fpage>
        <lpage>2212</lpage>
        <pub-id pub-id-type="doi">10.1136/annrheumdis-2014-205980</pub-id>
        <pub-id pub-id-type="pmid">25261579</pub-id>
      </element-citation>
    </ref>
    <ref id="bib37">
      <label>37</label>
      <element-citation publication-type="journal" id="sref37">
        <person-group person-group-type="author">
          <name>
            <surname>Deckx</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Heymans</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Papageorgiou</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>The diverse functions of osteoglycin: a deceitful dwarf, or a master regulator of disease?</article-title>
        <source>Faseb. J.</source>
        <volume>30</volume>
        <year>2016</year>
        <fpage>2651</fpage>
        <lpage>2661</lpage>
        <pub-id pub-id-type="doi">10.1096/fj.201500096R</pub-id>
        <pub-id pub-id-type="pmid">27080639</pub-id>
      </element-citation>
    </ref>
    <ref id="bib38">
      <label>38</label>
      <element-citation publication-type="journal" id="sref38">
        <person-group person-group-type="author">
          <name>
            <surname>Chou</surname>
            <given-names>C.-H.</given-names>
          </name>
          <name>
            <surname>Attarian</surname>
            <given-names>D.E.</given-names>
          </name>
          <name>
            <surname>Wisniewski</surname>
            <given-names>H.-G.</given-names>
          </name>
          <name>
            <surname>Band</surname>
            <given-names>P.A.</given-names>
          </name>
          <name>
            <surname>Kraus</surname>
            <given-names>V.B.</given-names>
          </name>
        </person-group>
        <article-title>TSG-6 - a double-edged sword for osteoarthritis (OA)</article-title>
        <source>Osteoarthritis Cartilage</source>
        <volume>26</volume>
        <year>2018</year>
        <fpage>245</fpage>
        <lpage>254</lpage>
        <pub-id pub-id-type="doi">10.1016/j.joca.2017.10.019</pub-id>
        <pub-id pub-id-type="pmid">29129649</pub-id>
      </element-citation>
    </ref>
    <ref id="bib39">
      <label>39</label>
      <element-citation publication-type="journal" id="sref39">
        <person-group person-group-type="author">
          <name>
            <surname>Tsezou</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>Osteoarthritis year in review 2014: genetics and genomics</article-title>
        <source>Osteoarthritis Cartilage</source>
        <volume>22</volume>
        <year>2014</year>
        <fpage>2017</fpage>
        <lpage>2024</lpage>
        <pub-id pub-id-type="doi">10.1016/j.joca.2014.07.024</pub-id>
        <pub-id pub-id-type="pmid">25456297</pub-id>
      </element-citation>
    </ref>
    <ref id="bib40">
      <label>40</label>
      <element-citation publication-type="journal" id="sref40">
        <person-group person-group-type="author">
          <name>
            <surname>Shen</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Gan</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>L.</given-names>
          </name>
        </person-group>
        <article-title>lncRNA MALAT1 promotes chondrocyte proliferation by inhibiting MiR-127-5p</article-title>
        <source>Int. J. Clin. Exp. Med.</source>
        <volume>13</volume>
        <year>2020</year>
        <fpage>3978</fpage>
        <lpage>3988</lpage>
        <ext-link ext-link-type="uri" xlink:href="http://www.ijcem.com/" id="intref0075">www.ijcem.com/</ext-link>
        <comment>accessed</comment>
      </element-citation>
    </ref>
    <ref id="bib41">
      <label>41</label>
      <element-citation publication-type="journal" id="sref41">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>You</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Gong</surname>
            <given-names>Z.</given-names>
          </name>
        </person-group>
        <article-title>Therapeutic effect of Resveratrol in the treatment of osteoarthritis via the MALAT1/miR-9/NF-κB signaling pathway</article-title>
        <source>Exp. Ther. Med.</source>
        <volume>19</volume>
        <year>2020</year>
        <fpage>2343</fpage>
        <lpage>2352</lpage>
        <pub-id pub-id-type="doi">10.3892/etm.2020.8471</pub-id>
        <pub-id pub-id-type="pmid">32104302</pub-id>
      </element-citation>
    </ref>
    <ref id="bib42">
      <label>42</label>
      <element-citation publication-type="journal" id="sref42">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>H.</given-names>
          </name>
        </person-group>
        <article-title>LncRNA MALAT1 mediates proliferation of LPS treated-articular chondrocytes by targeting the miR-146a-PI3K/Akt/mTOR axis</article-title>
        <source>Life Sci.</source>
        <volume>254</volume>
        <year>2020</year>
        <fpage>116801</fpage>
        <pub-id pub-id-type="doi">10.1016/J.LFS.2019.116801</pub-id>
        <pub-id pub-id-type="pmid">31472145</pub-id>
      </element-citation>
    </ref>
    <ref id="bib43">
      <label>43</label>
      <element-citation publication-type="journal" id="sref43">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>L.</given-names>
          </name>
        </person-group>
        <article-title>LncRNA MALAT1 promotes osteoarthritis by modulating miR-150-5p/AKT3 axis</article-title>
        <source>Cell Biosci.</source>
        <volume>9</volume>
        <year>2019</year>
        <fpage>54</fpage>
        <pub-id pub-id-type="doi">10.1186/s13578-019-0302-2</pub-id>
        <pub-id pub-id-type="pmid">31304004</pub-id>
      </element-citation>
    </ref>
    <ref id="bib44">
      <label>44</label>
      <element-citation publication-type="journal" id="sref44">
        <person-group person-group-type="author">
          <name>
            <surname>Liang</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>A.-M.</given-names>
          </name>
          <name>
            <surname>Ge</surname>
            <given-names>H.-X.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y.-Y.</given-names>
          </name>
          <name>
            <surname>Tu</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>MALAT1/miR-127-5p regulates osteopontin (OPN)-Mediated proliferation of human chondrocytes through PI3K/akt pathway</article-title>
        <source>J. Cell. Biochem.</source>
        <volume>119</volume>
        <year>2018</year>
        <fpage>431</fpage>
        <lpage>439</lpage>
        <pub-id pub-id-type="doi">10.1002/jcb.26200</pub-id>
        <pub-id pub-id-type="pmid">28590075</pub-id>
      </element-citation>
    </ref>
    <ref id="bib45">
      <label>45</label>
      <element-citation publication-type="journal" id="sref45">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Ren</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y.</given-names>
          </name>
        </person-group>
        <article-title>LncRNA MALAT1/MiR-145 adjusts IL-1β-induced chondrocytes viability and cartilage matrix degradation by regulating ADAMTS5 in human osteoarthritis</article-title>
        <source>Yonsei Med. J.</source>
        <volume>60</volume>
        <year>2019</year>
        <fpage>1081</fpage>
        <pub-id pub-id-type="doi">10.3349/ymj.2019.60.11.1081</pub-id>
        <pub-id pub-id-type="pmid">31637891</pub-id>
      </element-citation>
    </ref>
    <ref id="bib46">
      <label>46</label>
      <element-citation publication-type="journal" id="sref46">
        <person-group person-group-type="author">
          <name>
            <surname>Poole</surname>
            <given-names>A.H.</given-names>
          </name>
        </person-group>
        <article-title>How has your science data grown? Digital curation and the human factor: a critical literature review</article-title>
        <source>Arch. Sci.</source>
        <volume>15</volume>
        <year>2015</year>
        <fpage>101</fpage>
        <lpage>139</lpage>
        <pub-id pub-id-type="doi">10.1007/s10502-014-9236-y</pub-id>
      </element-citation>
    </ref>
    <ref id="bib47">
      <label>47</label>
      <element-citation publication-type="journal" id="sref47">
        <person-group person-group-type="author">
          <name>
            <surname>Cope</surname>
            <given-names>P.J.</given-names>
          </name>
          <name>
            <surname>Ourradi</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Sharif</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Models of osteoarthritis: the good, the bad and the promising</article-title>
        <source>Osteoarthritis Cartilage</source>
        <volume>27</volume>
        <year>2019</year>
        <fpage>230</fpage>
        <lpage>239</lpage>
        <pub-id pub-id-type="doi">10.1016/J.JOCA.2018.09.016</pub-id>
        <pub-id pub-id-type="pmid">30391394</pub-id>
      </element-citation>
    </ref>
    <ref id="bib48">
      <label>48</label>
      <element-citation publication-type="journal" id="sref48">
        <person-group person-group-type="author">
          <name>
            <surname>Poste</surname>
            <given-names>G.</given-names>
          </name>
        </person-group>
        <article-title>Bring on the biomarkers</article-title>
        <source>Nature</source>
        <volume>469</volume>
        <year>2011</year>
        <fpage>156</fpage>
        <lpage>157</lpage>
        <pub-id pub-id-type="doi">10.1038/469156a</pub-id>
        <pub-id pub-id-type="pmid">21228852</pub-id>
      </element-citation>
    </ref>
  </ref-list>
  <sec id="appsec1" sec-type="supplementary-material">
    <label>Appendix A</label>
    <title>Supplementary data</title>
    <p id="p0215">The following are the Supplementary data to this article:<supplementary-material content-type="local-data" id="mmc1"><caption><title>Multimedia component 1</title></caption><media xlink:href="mmc1.pdf"><alt-text>Multimedia component 1</alt-text></media></supplementary-material><supplementary-material content-type="local-data" id="mmc2"><caption><title>Multimedia component 2</title></caption><media xlink:href="mmc2.txt"><alt-text>Multimedia component 2</alt-text></media></supplementary-material><supplementary-material content-type="local-data" id="mmc3"><caption><title>Multimedia component 3</title></caption><media xlink:href="mmc3.txt"><alt-text>Multimedia component 3</alt-text></media></supplementary-material><supplementary-material content-type="local-data" id="mmc4"><caption><title>Multimedia component 4</title></caption><media xlink:href="mmc4.xlsx"><alt-text>Multimedia component 4</alt-text></media></supplementary-material><supplementary-material content-type="local-data" id="mmc5"><caption><title>Multimedia component 5</title></caption><media xlink:href="mmc5.txt"><alt-text>Multimedia component 5</alt-text></media></supplementary-material></p>
  </sec>
  <ack id="ack0010">
    <title>Acknowledgments</title>
    <p id="p0210">We thank Haroon Chaudhry, Zara Malik, Dr. Anne-Christin Hauschild, Andrea Rossos and Dr. Stuart Faulkner for their contribution to data curation.</p>
  </ack>
  <fn-group>
    <fn id="appsec2" fn-type="supplementary-material">
      <label>Appendix A</label>
      <p id="p0220">Supplementary data to this article can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ocarto.2022.100237" id="intref0060">https://doi.org/10.1016/j.ocarto.2022.100237</ext-link>.</p>
    </fn>
  </fn-group>
</back>
